Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 38

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 38
---
 your shares are held in the name of a bank, broker or other nominee and you previously provided voting                                                                           
 instructions to your bank, broker or other nominee, you should follow the instructions provided by your bank, broker or other nominee to revoke or change your voting instructions. |

21

| Q: | Where can I find the voting results of the TuHURA and Kineta special meetings? |

| A: | The preliminary voting results for each special meeting will be announced at that special meeting. In addition,                                                                                                                                 
 within four Business Days following certification of the final voting results, each of TuHURA and Kineta will file the final voting results of its respective special meeting (or, if the final voting results have not yet been certified, the 
 preliminary results) with the SEC on a Current Report on Form 8-K.                                                                                                                                                                              |

| Q: | If I am a Kineta stockholder and I do not favor the Mergers, what are my rights? |

| A: | If you are a Kineta stockholder not in favor of the Mergers, you may vote your shares of Kineta Common Stock                                                                                                                     
 against the Merger Agreement Proposal. Information about how Kineta stockholders may vote on the proposals being considered in connection with the Mergers can be found under the section entitled “The Kineta Special Meeting”. |

| Kineta stockholders and beneficial owners who do not vote in favor of the Mergers may be entitled to appraisal                                                                                                                                           
 rights under the DGCL. For more information, see the section entitled “Appraisal Rights”. In addition, a copy of Section 262 of the DGCL is attached as Annex B to this joint proxy statement/prospectus. Holders of Kineta Common                       
 Stock who wish to seek appraisal of their shares are in any case encouraged to seek the advice of their legal counsel and financial advisors with respect to the exercise of appraisal rights due to the complexity of the appraisal process. Failure to 
 strictly comply with Section 262 of the DGCL may result in your waiver of, or inability to, exercise appraisal rights.                                                                                                                                   |

| Q: | Are there any risks that I should consider in deciding whether to vote for the approval of the Authorized 
 Share Increase Proposal or the Merger Agreement Proposal?                                                 |

| A: | Yes. You should read and carefully consider the risk factors set forth in the section entitled “Risk 
 Factors”.                                                                                            |

| Q: | What happens if I sell my shares of TuHURA or Kineta Common